A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Abramson Cancer Center at Penn Medicine
Fondazione Italiana Linfomi - ETS
4SC AG
University of Pittsburgh
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
Eastern Cooperative Oncology Group
Genmab
Genmab
Atara Biotherapeutics
Centre for Human Drug Research, Netherlands
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Soligenix
4SC AG
Rochester Skin Lymphoma Medical Group, PLLC
Northwestern University
Novartis
Roswell Park Cancer Institute
AbbVie
Fred Hutchinson Cancer Center
Takeda
miRagen Therapeutics, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Mayo Clinic
Helsinn Therapeutics (U.S.), Inc
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
University of Wisconsin, Madison
National Cancer Institute (NCI)
University of Wisconsin, Madison
Mayo Clinic
Roswell Park Cancer Institute